Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
176750.KQ
HOLDDuChemBIO Co.,Ltd. · Healthcare · South Korea · $110M · Avg Vol: $117K/d
46
StockRankQ
63
V
46
M
28
P/E (TTM)
27.2x
ROE
14.9%
D/E
0.4x
Dividend %
—
COMPANY DESCRIPTION
DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 21.1M | 22.6M | 23.2M | 25.1M | 6.0% |
| EPS | -0.06 | 0.10 | 0.19 | 0.15 | 23.6% |
| Shares | 27.0M | 27.0M | 28.5M | 28.3M | +4.9% |
| Debt | 17.7M | 14.2M | 11.4M | 15.9M | -3.4% |
| Equity | 11.5M | 14.2M | 28.0M | 32.1M | 40.9% |
| Op CF | 5.4M | 5.5M | 4.6M | 6.5M | 6.5% |
| Inv CF | -0.2M | -0.8M | -1.2M | -0.5M | — |
| Fin CF | -4.3M | -5.1M | 2.3M | -2.9M | — |
Loading...
PRICE (1Y)-31.6%
SMA 50SMA 200
Close
$3.97
RSI (14)
57.1
52W High
$8.32
From 52W High
0.5%
SCORE BREAKDOWN
Quality
63
ROIC
13.0%81.2
ROE
14.9%82.7
GP/Assets
19.2%45.2
Op. Margin
12.9%71.5
FCF/Assets
12.6%91.2
Piotroski
666.7
Int. Cover
7.3x55.8
D/E Ratio
0.45x34.5
Current Ratio
1.70x30.3
Value
46
P/E (TTM)
27.2x40.3
EV/EBITDA
11.9x58.9
P/FCF
17.2x61.8
P/B
3.6x36.0
P/S
4.5x43.9
Div Yield
—N/A
Momentum
28
52W High %
48%22.9
RS 6M
-133%5.0
SMA 50/200
0.85x23.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
131%88.7
FUNDAMENTALS
Market Cap
$110M
P/E (Forward)
—
Gross Margin
38.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 176750.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 176750.KQ | DuChemBIO Co.,Ltd.(you) | $110M | 46 | HOLD |
| 003120.KS | Ilsung Is Co., Ltd. | $91M | 47 | HOLD |
| 007570.KS | Ilyang Pharmaceutical Co.,Ltd | $92M | 43 | HOLD |
| 102460.KS | REYON Pharmaceutical Co., Ltd. | $118M | 38 | HOLD |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $98M | 55 | HOLD |
| 000230.KS | Ildong Holdings Co., Ltd. | $57M | 48 | HOLD |
| 002720.KS | Kukje Pharma Co., Ltd. | $55M | 47 | HOLD |
| 293480.KS | Hana Pharm Co., Ltd. | $103M | 61 | HOLD |
| 003220.KS | Daewon Pharmaceutical Co., Ltd. | $116M | 28 | SELL |
| 200670.KQ | Humedix Co., Ltd. | $191M | 55 | HOLD |
Peer medians: ROE 0.1% · P/E 16.1x · Gross margin 43.8%